Royce & Associates LP Enovis Corp Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Enovis Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,403,685 shares of ENOV stock, worth $104 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
2,403,685
Previous 2,057,368
16.83%
Holding current value
$104 Million
Previous $93 Million
11.28%
% of portfolio
0.98%
Previous 0.91%
Shares
11 transactions
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.2MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$286 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$234 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$233 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$130 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$129 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.33B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...